Diabetes Research in Pediatrics? The International Society Has Your Back
Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!
Breakthrough T1D Timeline: Stem Cell Therapies
Stem cells have the potential to lead to treatments for type 1 diabetes, but it has taken Breakthrough T1D more…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
At the ADA’s Scientific Sessions, Breakthrough T1D scientists presented on some of the most important topics, all with the same…
Breakthrough T1D Heads—In Person!—to ADA’s 82nd Scientific Sessions
From June 3-7, diabetes researchers around the world will gather—in person!—at the American Diabetes Association’s 82nd Scientific Sessions. #JDRFxADA
100, 100: Ending Diabetic Eye Disease, Forever
Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of…
Top Researchers Gather for the 15th ATTD Conference
Leading researchers gathered, in person, for the annual meeting of the ATTD Conference (April 27-30), featuring 30+ studies presented by…
ATTD Conference Brings Together Top Minds in Diabetes Research
Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from…
100, 100: Breakthrough T1D Research Leads to a New Class of Glucose-Lowering Agents
You’ve seen the ads: Victoza®. Ozempic®. Trulicity®. But did you know that these drugs came about, in part, because of…
FDA Approval of Senseonics Eversense® CGM for Use for Up to 6 Months
FDA approves Senseonics Eversense® E3, the first long-term implantable CGM system, and the E3 includes technology that extends the use…
100 Years, 100 Breakthrough T1D Scientists: The BB Rat—An Animal Model of Type 1 Diabetes
In 1974, a colony of non-diabetic BB rats develops diabetes. Examination of their pancreases revealed that they had no beta…
